BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12557231)

  • 1. Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
    Xinh PT; Tri NK; Nagao H; Nakazato H; Taketazu F; Fujisawa S; Yagasaki F; Chen YZ; Hayashi Y; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2003 Mar; 36(3):313-6. PubMed ID: 12557231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
    Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
    Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
    Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).
    Shimizu S; Suzukawa K; Kodera T; Nagasawa T; Abe T; Taniwaki M; Yagasaki F; Tanaka H; Fujisawa S; Johansson B; Ahlgren T; Yokota J; Morishita K
    Genes Chromosomes Cancer; 2000 Mar; 27(3):229-38. PubMed ID: 10679911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the breakpoints at 1p36.2 and 3p21.3 in an AML(M3) patient who had t(1;3)(p36.2;p21.3) at the third relapse.
    Tri NK; Xinh PT; Nagao H; Izumi T; Ozawa K; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2002 Dec; 35(4):365-7. PubMed ID: 12378531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
    Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
    Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(1;3)(p36;p21) is a recurring therapy-related translocation.
    Sato Y; Izumi T; Kanamori H; Davis EM; Miura Y; Larson RA; Le Beau MM; Ozawa K; Rowley JD
    Genes Chromosomes Cancer; 2002 Jun; 34(2):186-92. PubMed ID: 11979552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
    De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
    Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
    Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
    Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
    Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
    Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
    Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
    Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
    Tosi S; Hughes J; Scherer SW; Nakabayashi K; Harbott J; Haas OA; Cazzaniga G; Biondi A; Kempski H; Kearney L
    Genes Chromosomes Cancer; 2003 Oct; 38(2):191-200. PubMed ID: 12939747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R
    Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
    Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
    Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia.
    Wieser R; Volz A; Vinatzer U; Gardiner K; Jäger U; Mitterbauer M; Ziegler A; Fonatsch C
    Biochem Biophys Res Commun; 2000 Jun; 273(1):239-45. PubMed ID: 10873593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
    Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
    Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.